Talk:TCDD project: Difference between revisions

From Opasnet
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(8 intermediate revisions by the same user not shown)
Line 21: Line 21:
|S117
|S117
|✔
|✔
|✔ (Motiliteetti vai Dioksiini?)
|✔
|
|
|----
|----
|rowspan="11"|[[TCDD brain lesions and eating|Brain lesions and eating]]
|rowspan="10"|[[TCDD brain lesions and eating|Brain lesions and eating]]
|S78
|S78
|✔
|✔
Line 32: Line 32:
|S84
|S84
|✔
|✔
|✔ (PVN pieleen ?)
|✔
|
|
|----
|----
Line 58: Line 58:
|✔
|✔
|✔
|✔
|
|----
|S151
| (Onko vihko "VMH-leesio pilottikoe Long-Evanseille" tämä?)
|✔ (Insuliini vai Aivoleesiot?)
|
|
|----
|----
Line 86: Line 81:
|✔
|✔
|----
|----
|rowspan="9"|[[TCDD dioxin dose response|Dioxin dose response]]
|rowspan="8"|[[TCDD dioxin dose response|Dioxin dose response]]
|S62
|S62
|
|
Line 98: Line 93:
|----
|----
|S83  
|S83  
|
|✔
|
|✔
|
|
|----
|----
|S87  
|S87  
|
|✔
|
|✔
|
|----
|S117
|
|
|
|
|----
|----
|S137  
|S137  
|
|✔
|
|
|
|
|----
|----
|S149  
|S149  
|
|✔
|
|
|
|
Line 125: Line 115:
|
|
|
|
|
|✔
|----
|----
|S217, S217b, S226, S227, S228
|S217, S217b, S226, S227, S228
Line 133: Line 123:
|----
|----
|rowspan="17"|[[TCDD chocolate|Chocolate]]
|rowspan="17"|[[TCDD chocolate|Chocolate]]
|S113  
|S113
|
|✔ (Samat kaksi vihkoa S109 kanssa)
|✔
|✔
|
|
|----
|----
|S239  
|S239  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S240  
|S240  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S243
|S243
|
|✔
|✔
|✔
|✔
|✔
Line 201: Line 191:
|
|
|
|
|
|✔
|----
|----
|S276
|S276
Line 220: Line 210:
|rowspan="10"|[[TCDD tube feeding|Tube feeding]]
|rowspan="10"|[[TCDD tube feeding|Tube feeding]]
|S37  
|S37  
|
|✔ (Sama vihko S38 kanssa)
|✔
|✔
|
|
|----
|----
|S41  
|S41  
|
|✔
|✔
|✔
|
|
|----
|----
|S49  
|S49  
|
|✔
|✔
|✔
|
|
|----
|----
|S88  
|S88  
|
|✔
|✔
|✔
|
|
|----
|----
|S109  
|S109  
|
|✔ (Samat kaksi vihkoa S113 kanssa, Suklaa-kansiossa)
|
|
|
|
|----
|----
|S118  
|S118  
|
|✔ (Sama vihko S116 kanssa)
|✔
|✔
|
|
|----
|----
|S124  
|S124  
|
|✔
|
|
|
|
|----
|----
|S131  
|S131  
|
|✔
|✔
|✔
|
|
|----
|----
|S188  
|S188  
|✔
|
|
|
|✔
|
|----
|----
|S191
|S191
|
|✔
|
|
|
|
Line 271: Line 261:
|[[TCDD route of exposure|Route of exposure]]
|[[TCDD route of exposure|Route of exposure]]
|S132
|S132
|
|✔
|✔
|✔
|
|
Line 277: Line 267:
|rowspan="4"|[[TCDD leptin|Leptin]]
|rowspan="4"|[[TCDD leptin|Leptin]]
|S164  
|S164  
|
|✔
|✔
|✔
|
|
|----
|----
|S183  
|S183  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S213  
|S213  
|
|✔
|✔
|
|✔
|✔
|----
|----
|ZUCKER
|ZUCKER
|
|✔
|✔
|
|✔
|✔
|----
|----
|rowspan="18"|[[TCDD crossbreeding|Crossbreeding]]
|rowspan="19"|[[TCDD crossbreeding|Crossbreeding]]
|S187  
|S187  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S201  
|S201  
|✔
|
|
|
|✔
|
|----
|----
|S206  
|S206  
|✔
|
|
|
|✔
|
|----
|----
|S209  
|S209  
|✔
|
|
|
|✔
|
|----
|----
|S212  
|S212  
|✔
|
|
|
|✔
|
|----
|----
|S215  
|S215  
|
|
|
|
|
|✔
|----
|----
|S216  
|S216  
|
|
|
|
|
|✔
|----
|----
|S223  
|S223  
|
|
|
|
|
|✔
|----
|----
|S229  
|S229  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S230  
|S230  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S236  
|S236  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S238  
|S238  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S242  
|S242  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S248  
|S248  
|
|
|
|
|
|✔
|----
|----
|S260  
|S260  
|
|
|
|
|
|✔
|----
|----
|S275  
|S275  
|
|
|
|
|✔
|----
|S284
|
|
|
|✔
|----
|----
|S284
|S392
|
|
|
|
|
|
|----
|----
|S392
|Risteytyskoe 1988
|
|
|
|
Line 391: Line 386:
|
|
|
|
|
|✔
|----
|----
|S266  
|S266  
|✔
|
|
|
|✔
|
|----
|----
|S271  
|S271  
|✔
|
|
|
|✔
|
|----
|----
|S279  
|S279  
|✔
|
|
|
|✔
|
|----
|----
|S311  
|S311  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S324  
|S324  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S325  
|S325  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S326  
|S326  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S349
|S349
|
|✔
|✔
|✔
|
|
|----
|----
|rowspan="11"|[[TCDD resistance|Resistance and its development]]
|rowspan="10"|[[TCDD resistance|Resistance and its development]]
|S222  
|S222  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S224  
|S224  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S241  
|S241  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S246  
|S246  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S259  
|S259  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S267  
|S267  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S277  
|S277  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S282  
|S282  
|✔
|
|
|
|✔
|
|----
|S283
|
|
|
|----
|----
|S289  
|S289  
|
|✔
|✔
|
|✔
|✔
|----
|----
|S292
|S292
|
|✔
|✔
|
|✔
|✔
|----
|----
|rowspan="4"|[[TCDD insulin and glucose|Insulin and glucose]]
|rowspan="4"|[[TCDD insulin and glucose|Insulin and glucose]]
|S72  
|S72  
|
|✔ (Sama vihko S71 kanssa)
|✔
|✔
|
|
|----
|----
|S151  
|S151
|
|
|✔
|✔
Line 506: Line 496:
|----
|----
|S178
|S178
|
|✔
|✔
|✔
|
|

Latest revision as of 07:42, 26 August 2016

TCDD archive checklist
Series Experiment Notebook Files T2b
Motility S36 ✔ ✔
S40 ✔ ✔
S117 ✔ ✔
Brain lesions and eating S78 ✔ ✔
S84 ✔ ✔
S106 ✔ ✔
S125 ✔ ✔
S128 ✔ ✔
S141 ✔ ✔
S144 ✔ ✔
S174 ✔ ✔
S196 ✔ ✔
Valjakka et al.
Tumor promotion S186 ✔ ✔
Dioxin dose response S62
S64
S83 ✔ ✔
S87 ✔ ✔
S137 ✔
S149 ✔
S192 ✔
S217, S217b, S226, S227, S228 ✔ ✔
Chocolate S113 ✔ (Samat kaksi vihkoa S109 kanssa) ✔
S239 ✔ ✔ ✔
S240 ✔ ✔ ✔
S243 ✔ ✔ ✔
S250 ✔ ✔
S251 ✔ ✔
S252 ✔ ✔
S253 ✔ ✔
S254 ✔ ✔
S261, S262, S264 ✔ ✔
S263 ✔ ✔
S269 ✔ ✔
S270 ✔ ✔
S273 ✔
S276 ✔ ✔
S278 ✔ ✔
S280 ✔ ✔
Tube feeding S37 ✔ (Sama vihko S38 kanssa) ✔
S41 ✔ ✔
S49 ✔ ✔
S88 ✔ ✔
S109 ✔ (Samat kaksi vihkoa S113 kanssa, Suklaa-kansiossa)
S118 ✔ (Sama vihko S116 kanssa) ✔
S124 ✔
S131 ✔ ✔
S188 ✔ ✔
S191 ✔
Route of exposure S132 ✔ ✔
Leptin S164 ✔ ✔
S183 ✔ ✔ ✔
S213 ✔ ✔ ✔
ZUCKER ✔ ✔ ✔
Crossbreeding S187 ✔ ✔ ✔
S201 ✔ ✔
S206 ✔ ✔
S209 ✔ ✔
S212 ✔ ✔
S215 ✔
S216 ✔
S223 ✔
S229 ✔ ✔ ✔
S230 ✔ ✔ ✔
S236 ✔ ✔ ✔
S238 ✔ ✔ ✔
S242 ✔ ✔ ✔
S248 ✔
S260 ✔
S275 ✔
S284 ✔
S392
Risteytyskoe 1988
Biliverdin S256 ✔
S266 ✔ ✔
S271 ✔ ✔
S279 ✔ ✔
S311 ✔ ✔ ✔
S324 ✔ ✔ ✔
S325 ✔ ✔ ✔
S326 ✔ ✔ ✔
S349 ✔ ✔
Resistance and its development S222 ✔ ✔ ✔
S224 ✔ ✔ ✔
S241 ✔ ✔ ✔
S246 ✔ ✔ ✔
S259 ✔ ✔ ✔
S267 ✔ ✔ ✔
S277 ✔ ✔ ✔
S282 ✔ ✔
S289 ✔ ✔ ✔
S292 ✔ ✔ ✔
Insulin and glucose S72 ✔ (Sama vihko S71 kanssa) ✔
S151 ✔
S172
S178 ✔ ✔
Fatty acids S158 ✔
S168 ✔
Retrieved from "https://en.opasnet.org/index.php?title=Talk:TCDD_project&oldid=39868"